Target intelligence / Profile preview

RNA, U6 small nuclear 822, pseudogene (RNU6-822P)

Target
RNU6-822P
Molecular classification
Other (pseudogene), Non-coding RNA gene (pseudogenic fragment of small nuclear RNA gene)
01

Overview

**RNA, U6 small nuclear 822, pseudogene (RNU6-822P)** is a **pseudogene** derived from a U6 small nuclear RNA (snRNA) gene[4][5]. U6 snRNA itself is a highly conserved small nuclear RNA component of the spliceosome, critical for pre-mRNA splicing through ribonucleoprotein activity in the nucleus[1][3]. However, RNU6-822P is a processed pseudogene, meaning it is a non-functional, non-coding genomic sequence with high sequence similarity to the functional U6 snRNA gene but lacks the ability to produce functional RNA or protein product[4][5]. RNU6-822P is annotated in reference databases (e.g., NCBI Gene: 106479930) with no confirmed biological or pathological roles and is not considered a therapeutic, pharmacological, or diagnostic target[4][5]. **Key Notes:** - This locus should not be confused with the active U6 small nuclear RNA gene, which is functionally essential in the spliceosome[1][3]. - There are no known, validated drug interactions, clinical biomarkers, or disease associations for this pseudogene. - Pseudogenes like RNU6-822P may sometimes be transcribed, but there is no evidence that this is the case here, nor is there any evidence for functional roles[4][5].

Other names
RNU6-822P
02

Biological functions

None (does not have known biological function as it is a pseudogene)
03

Disease associations

None (no evidence links RNU6-822P to disease)

Beyond the preview

Go deeper on RNA, U6 small nuclear 822, pseudogene (RNU6-822P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 822, pseudogene (RNU6-822P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call